IVT IBI302

IBI-302 · Innovent Biologics (Suzhou) Co. Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for IVT IBI302, covering 2024-06-28 to 2024-06-28. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Longer Interval of IVT IBI302 in Subjects With nAMD [Phase 2]